SCHEMBL1269770

SCHEMBL1269770

O=C(c1nc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2Cl)ccc1Sc1ccc(S(=O)(=O)N2CCOCC2)cc1)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 6/20 0.42
▸ PKM P14618 1/20 0.42
▸ EPHX2 P34913 2/20 0.42
▸ SCN9A Q15858 2/20 0.38
▸ SCN5A Q14524 1/20 0.38
▸ CCKBR P32239 1/20 0.38
▸ HTT P42858 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ USP2 O75604 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HCRTR1 O43613 1/20 0.36
▸ HCRTR2 O43614 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ IDH2 P48735 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269953 0.93 CCKBR (0.42) GAAEPHX2CCKBRMAPTMEN1
SCHEMBL1269628 0.93 CCKBR (0.43) GAAEPHX2CCKBRHTTMEN1
SCHEMBL1268682 0.90 KMT2A (0.43) GAAHTTMAPTMEN1ALDH1A1
SCHEMBL1269726 0.89 CCR6 (0.35) GAASCN9ASCN5ACCKBR
SCHEMBL1269830 0.87 GAA (0.43) GAAPKMEPHX2SCN9AHTT
SCHEMBL1269603 0.86 GAA (0.45) GAAPKMEPHX2SCN9ACCKBR
SCHEMBL1268685 0.86 GAA (0.43) GAAPKMEPHX2SCN9ASCN5A
SCHEMBL1268674 0.86 GAA (0.42) GAAPKMEPHX2SCN9AHTT
SCHEMBL1268781 0.85 CCKBR (0.38) GAASCN9ACCKBRALDH1A1HCRTR1
SCHEMBL1269586 0.84 PIK3C3 (0.38) GAASCN9ACCKBRHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG GAA 1704/4885PKM 3049/4885EPHX2 1942/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG GAA 1704/4885PKM 3049/4885EPHX2 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback